Literature DB >> 7987109

Cardiac transplantation for AL amyloidosis.

R Hall1, P N Hawkins.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 7987109      PMCID: PMC2541916          DOI: 10.1136/bmj.309.6962.1135

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  10 in total

1.  Treatment of AL amyloidosis with melphalan, prednisone, and colchicine.

Authors:  M D Benson
Journal:  Arthritis Rheum       Date:  1986-05

Review 2.  Primary systemic amyloidosis--a diagnostic primer.

Authors:  M A Gertz; R A Kyle
Journal:  Mayo Clin Proc       Date:  1989-12       Impact factor: 7.616

3.  Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.

Authors:  P N Hawkins; S Richardson; J E MacSweeney; A D King; D M Vigushin; J P Lavender; M B Pepys
Journal:  Q J Med       Date:  1993-06

4.  Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.

Authors:  G Holmgren; B G Ericzon; C G Groth; L Steen; O Suhr; O Andersen; B G Wallin; A Seymour; S Richardson; P N Hawkins
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

5.  Response rates and survival in primary systemic amyloidosis.

Authors:  M A Gertz; R A Kyle; P R Greipp
Journal:  Blood       Date:  1991-01-15       Impact factor: 22.113

6.  Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component.

Authors:  P N Hawkins; M J Myers; J P Lavender; M B Pepys
Journal:  Lancet       Date:  1988-06-25       Impact factor: 79.321

Review 7.  Amyloidosis (AL). Clinical and laboratory features in 229 cases.

Authors:  R A Kyle; P R Greipp
Journal:  Mayo Clin Proc       Date:  1983-10       Impact factor: 7.616

8.  Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival.

Authors:  L Cueto-Garcia; G S Reeder; R A Kyle; D L Wood; J B Seward; J Naessens; K P Offord; P R Greipp; W D Edwards; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1985-10       Impact factor: 24.094

9.  Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.

Authors:  P N Hawkins; J P Lavender; M B Pepys
Journal:  N Engl J Med       Date:  1990-08-23       Impact factor: 91.245

10.  Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis.

Authors:  P N Hawkins; S Richardson; D M Vigushin; J David; C R Kelsey; R E Gray; M A Hall; P Woo; J P Lavender; M B Pepys
Journal:  Arthritis Rheum       Date:  1993-06
  10 in total
  7 in total

Review 1.  Amyloidosis.

Authors:  M F Khan; R H Falk
Journal:  Postgrad Med J       Date:  2001-11       Impact factor: 2.401

2.  Restrictive Cardiomyopathy.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

3.  Diagnosis and treatment of amyloidosis.

Authors:  P N Hawkins
Journal:  Ann Rheum Dis       Date:  1997-11       Impact factor: 19.103

4.  Long term results of heart transplantation in patients with amyloid heart disease.

Authors:  S W Dubrey; M M Burke; A Khaghani; P N Hawkins; M H Yacoub; N R Banner
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 5.  Amyloid in the cardiovascular system: a review.

Authors:  I Kholová; H W M Niessen
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

Review 6.  Heart transplantation in cardiac amyloidosis.

Authors:  Matthew Sousa; Gregory Monohan; Navin Rajagopalan; Alla Grigorian; Maya Guglin
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

7.  Cardiac Amyloidosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.